Who
Michael Anthony White
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, IDEAYA Biosciences.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $1.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Oct 2021
- Last trade
- 30 Jan 2026
- Last filed
- 2 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jan 2026filed 2 Feb 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 30 Jan 2026filed 2 Feb 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 27 Feb 2025filed 28 Feb 2025 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —185,000 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —28,500 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Code M | $367K28,500 at $12.86 | filing |
| 29 May 2024filed 31 May 2024 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Sold | $1.0M27,649 at $36.23 | filing |
| 29 May 2024filed 31 May 2024 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Sold | $31K851 at $36.78 | filing |
| 1 Mar 2024filed 4 Mar 2024 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 24 Feb 2023filed 28 Feb 2023 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —165,000 at $0.00 | filing |
| 1 Mar 2022filed 2 Mar 2022 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —92,500 at $0.00 | filing |
| 25 Oct 2021filed 27 Oct 2021 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.